The BWEL Breast Cancer Weight Loss Study. Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (ALLIANCE A011401)
The BWEL Breast Cancer Weight Loss Study will look at whether losing weight, by eating less and exercising more, changes the risk of cancer recurrence in women who have been diagnosed with early breast cancer. The study will enroll more than 3,000 patients with breast cancer in the United States and Canada.
Participants will receive regular mailings on breast cancer topics and general health as well as invitations to attend online seminars that focus on breast cancer.
Participants will complete health questionnaires and take height and weight measurements and a fasting blood draw at different points throughout the study.
|Clinical Study Identifier||TX149689|
|Last Modified on||24 November 2020|
Select a piece of text and start making personal notes.
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.Learn more
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.Learn more
Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.Learn more
Congrats! You have your own personal workspace now.